Deferasirox
Inquiry
| Post Date: | Mar 24,2017 |
| Expiry Date: | Mar 24,2018 |
| Detailed Description: | Cas No. :201530-41-8 Available with the similar efficacy of deferoxamine in patients with transfusion-dependent ,help to improve the thalassemia patients with cardiac iron deposition |
| CAS Registry Number: | 201530-41-8 |
| Synonyms: | 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid;4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid;4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; |
| Molecular Formula: | C21H15N3O4 |
| Molecular Weight: | 373.3615 |
| Molecular Structure: | 
|
| Company: | HangZhou DoEasy Pharma Co.,Ltd. [ China ] |
| Contact: | Ms Xu |
| Tel: | 0086-571-88992753 |
| Fax: | 0086-571-28890605 |
| Email: | sales@deasypharma.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
